ProCE Banner Activity

An Interactive Decision Support Tool: Treatment Options From 5 Experts for People With Multiple Myeloma


Did you recently receive a diagnosis of multiple myeloma, or has your multiple myeloma come back or progressed? Answer a few multiple-choice questions in this interactive tool to get treatment suggestions from 5 experts to discuss with your doctor.

Released: October 24, 2023



Shaji K. Kumar

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Suzanne Lentzsch

Suzanne Lentzsch, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Sagar Lonial

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Joseph Mikhael

Joseph Mikhael, MD, MEd, FRCPC, FACP

Applied Cancer Research and Drug Discovery 
Translational Genomics Research Institute 
Phoenix, Arizona
Chief Medical Officer
International Myeloma Foundation 
HonorHealth Research Institute 
Scottsdale, Arizona

Saad Z. Usmani

Saad Z. Usmani, MD, MBA, FACP

Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College, Cornell University
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Karyopharm Therapeutics and Regeneron Pharmaceuticals, Inc.


Bristol Myers Squibb


Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc


Smart Patients

ProCE Banner